论文信息 - Results of PROFILE 1029, a Phase III Comparison of First‐Line Crizotinib versus Chemotherapy in East Asian Patients with ALK‐Positive Advanced Non–Small Cell Lung Cancer - 字舞流文

Results of PROFILE 1029, a Phase III Comparison of First‐Line Crizotinib versus Chemotherapy in East Asian Patients with ALK‐Positive Advanced Non–Small Cell Lung Cancer

T. Mok | Yi-long Wu | K. Wilner | Chun-Ming Tsai | Yuankai Shi | V. Sriuranpong | P. Selaru | Yiyun Tang | Shun Lu | J. Ho | C. Ong | Jianying Zhou | You Lu | E. Masters | C. Chung | S. Lu | C. Tsai